Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial

<p>Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in many countries. Outcome depends on access to mechanical ventilation and intensive care facilities and in settings where these are limited, mortality remains high. Administration of tetanus a...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C
Formato:	Journal article
Publicado em:	F1000Research 2018

Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial por Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C

Publicado em 2018

Journal article

Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial

Registros relacionados